President Bush probably will not reverse his position on stem cell research, even if it is mostly symbolic (embryos, after all, are destroyed every day in reproductive clinics–perhaps some White House press corps member would ask the president about this someday). The battle over therapeutic cloning, however, goes on in the Senate. And it appears that a ban on such cloning, lacking the support of Senators such as Orrin Hatch and Arlen Specter, probably would not muster a simple majority in the Senate–much less the 60 votes needed to break a filibuster. “The question is whether the Democrats and stem-cell supporters among Republicans can still hang tough,” says one observer, especially when contentious Supreme Court appointments loom in the near future. Some hope that passage of Proposition 71 in California will put pressure on President Bush to change his stem cell policy, a proposition that unfortunately looks unlikely from this president.
Embracing CX in the metaverse
More than just meeting customers where they are, the metaverse offers opportunities to transform customer experience.
Identity protection is key to metaverse innovation
As immersive experiences in the metaverse become more sophisticated, so does the threat landscape.
The modern enterprise imaging and data value chain
For both patients and providers, intelligent, interoperable, and open workflow solutions will make all the difference.
Scientists have created synthetic mouse embryos with developed brains
The stem-cell-derived embryos could shed new light on the earliest stages of human pregnancy.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.